Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Prepaid Assets (2016 - 2025)

Ptc Therapeutics (PTCT) has 14 years of Prepaid Assets data on record, last reported at $67.3 million in Q4 2025.

  • For Q4 2025, Prepaid Assets rose 52.67% year-over-year to $67.3 million; the TTM value through Dec 2025 reached $67.3 million, up 52.67%, while the annual FY2025 figure was $67.3 million, 52.67% up from the prior year.
  • Prepaid Assets reached $67.3 million in Q4 2025 per PTCT's latest filing, up from $64.2 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $150.5 million in Q4 2023 and bottomed at $23.6 million in Q1 2021.
  • Average Prepaid Assets over 5 years is $57.6 million, with a median of $49.6 million recorded in 2024.
  • Peak YoY movement for Prepaid Assets: skyrocketed 232.49% in 2023, then plummeted 70.7% in 2024.
  • A 5-year view of Prepaid Assets shows it stood at $54.7 million in 2021, then surged by 93.23% to $105.7 million in 2022, then skyrocketed by 42.43% to $150.5 million in 2023, then tumbled by 70.7% to $44.1 million in 2024, then soared by 52.67% to $67.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $67.3 million in Q4 2025, $64.2 million in Q3 2025, and $53.5 million in Q2 2025.